BMY Consolidation BreakoutI bought $72 puts for the 6/17 expiration today at $0.44. It does look like BMY is possibly breaking out into a move downward. I am extremely new to options so I can be totally wrong on this and would like to hear opinions. What do you guys think? BMYShortby CDR1334220
$BMY to the mid-low $60s?$BMY has held up remarkably well during the market sell off. That said, I don't think that it's going to escape the downside for that much longer. We've tested the $77-78 region multiple times and just rejected again. Seeing the price action today makes me think that it's finally time for BMY to fall lower. Once $BMY breaks $75, there's not much holding it up. I think we could see a fairly quick move down to the $60 range, at $65 which would be the first support and $61 which would be the second support. There's a chance it falls into the $50s but I'll likely take profits in the $60s as it's rare for BMY to have such a substantial drop. Let's see what happens over the coming days/weeks.Shortby benjihyam222
BMYCOULD be starting its breakout of the cup & handle that has been in the making for 20+ years that I first mentioned almost a year ago. Would like to see a little more push with good volume in the last hour of today, otherwise could chop around a little more. Target remains $130 if it goes.Longby Essendy0
BMY ShortBMY looking like a short here. Playing the triple top with the bottom of the channel as the target. Can always scale out with the drop. Options play. Cheap puts $$$$Shortby LoganTyler0
BMY BreakoutMy BMY position with stop loss and target. BMY is flagging after a long uptrend. The flag is a little extended and longer than i'd like, but regardless I opened a small position on the 5 min time frame.Longby PennantTrading0
$BMY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 33.33%. Longby EPSMomentum1
BMY triple top long term chart overbought!Bought 100 BMY May 6th $75 puts. Will add for each $1.00 increase. Shortby ShortSeller76Updated 772
BMY - ACCENDING TRIANGLETextbook pattern. Pharma products going through the roof due to covid and other reasons why this would be in high demand, also not too mention big investors adding to their portfolio. Plenty of info online, please research before investing obv. trade safe all.Longby BullnBear_MarketsUpdated 2
15/3/2022 NYSE BMYDesicion to Buy. Entry Price = $69.35. Target Price=$70.75. Stop Price=$67.95Longby Airecap_SuperUpdated 0
23/3/2022 NYSE BMYDesicion to Buy. Entry Price = $70.95. Target Price=$71.65. Stop Price=$70.25Longby Airecap_SuperUpdated 1
$BMY Bristol-Myers Squibb Company - Forming a baseThis might be forming a long-term base here. I'm long with a stop-loss at $62 (has to be a weekly close below $62). Part of my longest-term trading system.Longby InnVestor222
BMY Long Play Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company that engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Investments continue to flow into the healthcare industry and BMY is ripe to benefit. Adding it longLongby Wiseinvest1
$BMY with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BMY after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 20%.Longby EPSMomentum1
Bristol Myers Squibb Cup and Handle with 400% gain?Looks like a possible Cup and Handle with massive upside is forming in Bristol Myers Squibb. $340 TargetLongby KondrackiKarl331
BMY going South with a breeze. BMYImmediate targets 61, 59, 56, 53. Invalidation at 79. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safeShortby Rykin_Capital111
BMY Long Term LongHealthy pipeline. Sitting at 3.32% yield and 8.62 P/E (norm is 18.65 and 5Y norm is 11.17) with earnings growth rate approx. 6.18% since 2000 but has increased to 15-16% if you look at the 10Y and 5Y norms. Estimates are for about 4-6% the next 2 years. A+ Credit Rating 48LT Debt to Cap PT $96 by 2023 using a 7% earnings growth rate and 12 P/E HUGE saucer pattern -- technically. Longby CG_Financial1
Bristol Myers going South. BMYImmediate targets 61,59, 56, 53. Invalidation at 79. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safeShortby Rykin_Capital0
BMY to break out in the next several yearsBMY is presently in a wedge. Though a breakdown is certainly possible over the next decade, what are reasonable breakout levels to watch? This chart with Fib levels induced by the move from all-time lows to all-time highs gives some clues. Approximately $75 is first up, then approximately $120.Longby decaro0
BMY: Breakout of the long-term resistance level.An upward breakout of the long-term resistance level could lead to an increase in the area of 81. In the long-term, the growth could continue to the area of 93.Longby GeliumUpdated 1
$BMY bouncing off long-term support (4/5)Conviction: 4/5 might be better to buy when the stock goes over 1998 resistance General Thesis bouncing off of multi-cycle support (since 1974) Weekly RSI showing sliiight bullish divergence Growth Margins quite low compared to own history low growth Value very cheap Fundamentals low debt/asset ratio and plenty of cash to deal with short term debts Potential Risks expensive market... long-term resistance around 76 since 1998 Longby asdf0980
BMY Pays a dividend. This has a lot of different bullish patterns and if it falls through the floor, I'll laugh histaricly. Cup n' handle, bull-flaf, IHS. I'll leave a channel but feel free to find waldo! Cheers. Longby Candle_Vandal880
Bristol Myers Squibb Announces Dividend Increase and Additional BMY: Bristol-Myers Squibb Company 2021-12-13 06:59:00 Bristol Myers Squibb Announces Dividend Increase and Additional $15 Billion Share Repurchase AuthorizationLongby JetEquities0